Brazilian sustainable mycoprotein producer, Typcal, has opened a new facility in Pinhais to begin commercial-scale production of mycoprotein ingredients. The facility will allow the company to expand into Europe and Latin America by next year, offering fresh and powdered mycoprotein products, with two more solutions in development by the end of 2026. This marks a significant milestone for Typcal, as it becomes one of the few startups globally to advance from pilot to industrial scale in the new proteins segment.

The R$10 million investment from Brazilian investors and the Biotope biotech incubator program has enabled Typcal to establish the facility as South America's first large-scale fermentation plant dedicated to mycoprotein production. With a focus on building a portfolio of mycelium-based ingredients, the company aims to create a more positive food system for people and the planet. Typcal's commitment to innovation and sustainability is evident in its bold steps towards industrial-scale production and future growth in the mycoprotein market.